Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Elmer who wrote (225)	4/26/1998 5:32:00 AM
From: Troll_29	Read Replies (1) \| Respond to of 1127

With respect... Your view the stock has "done nothing" is not entirely accurate. Rather with the sales of the additional stock and other commitments HGSI has made during this time, your (and my) equity positions have been significantly eroded. OTH I do not know what progress has been made on their efforts to become a phara i.e. building plant, increasing staff, terminating the relationship with TIGR. Is there any consensus on whether the company has moved forward or backward? How many more years of increasing negative earnings lie ahead? How many more additional stock offerings are planned with the net effect of a reduction in negative EPS?